ASCO Personalized Meds Project Aims To Develop Outcomes Data For Off-Label Uses
This article was originally published in The Pink Sheet Daily
Executive Summary
Patients could receive cancer treatment at reduced or no cost for medicines selected based on molecular testing, and in return their data would be entered into a prospective registry, under a project ASCO is developing.